-
Nephrol. Dial. Transplant. · Nov 2013
Case ReportsOrlistat, an under-recognised cause of progressive renal impairment.
- Andrew K Coutinho and Gerald R Glancey.
- Renal Specialist Registrar, Renal Unit, Ipswich General Hospital, The Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK.
- Nephrol. Dial. Transplant. 2013 Nov 1; 28 Suppl 4: iv172-4.
AbstractObesity is an emerging risk factor for chronic kidney disease (CKD) in the developed world. Orlistat, an intestinal lipase inhibitor, used in the treatment of obesity is available as an over-the-counter medication across the European union and in many countries worldwide. It is associated with acute kidney injury (AKI). We present three adults, followed up from 1 to 6 years, who developed de novo or worsening renal impairment while on orlistat. Stopping the drug halted progression, but did not reverse the degree of renal impairment at presentation.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..